Transforming Hypertrophic Cardiomyopathy Care
The Senior Manager, Regulatory Affairs at Braveheart Bio will lead global regulatory submissions, focusing on EU and ex‑U.S. clinical trial applications. Reporting to the Vice President of Regulatory Affairs, the role manages CROs, coordinates cross‑functional deliverables, and handles health authority interactions to support trial start‑up and lifecycle management.
Advancing treatments to improve outcomes and quality of life for patients with hypertrophic cardiomyopathy and related heart conditions.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Transforming Hypertrophic Cardiomyopathy Care.
Right around the average for this role